BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4908595)

  • 21. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
    Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M
    Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immunizing effect and reactogenicity of two live attenuated mumps virus vaccines in Swedish schoolchildren.
    Christenson B; Heller L; Böttiger M
    J Biol Stand; 1983 Oct; 11(4):323-31. PubMed ID: 6643511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and Safety of an F-Genotype Attenuated Mumps Vaccine in Healthy 8- to 24-Month-Old Children.
    Liang Y; Che Y; Yang B; Zhan F; Li H; Guan X; Zhang Y; Yin Q; Li C; Li J; Zhao Z; Liu L; Jiang G; Liao Y; Xu X; Ye J; Ren Q; He Y; Feng M; Wang L; Fan S; Cui X; Wang Z; Li C; Xiao H; Liu R; Li Q; Jiang C; Liu J; Li Q
    J Infect Dis; 2019 Jan; 219(1):50-58. PubMed ID: 30085178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mumps-antibody formation in guinea pigs following a single virus application. Evaluation of live mumps-virus vaccine].
    Gladthe H; Abel C
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(2):202-7. PubMed ID: 5064723
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China.
    Zengel J; Phan SI; Pickar A; Xu P; He B
    Vaccine; 2017 Jul; 35(32):3988-3994. PubMed ID: 28623030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interstrain antigenic variability of mumps viruses.
    Heininger U; Bonhoeffer J
    Clin Infect Dis; 2008 Jan; 46(1):150-1. PubMed ID: 18171235
    [No Abstract]   [Full Text] [Related]  

  • 27. [Wide-spread inflammation of the parotid glands (mumps): an underestimated disease. II. Development, use, efficacy and safety of mumps vaccines].
    Gałazka A; Kraigher A; Robertson SE
    Przegl Epidemiol; 1998; 52(4):401-12. PubMed ID: 10321084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines.
    Peltola H; Kulkarni PS; Kapre SV; Paunio M; Jadhav SS; Dhere RM
    Clin Infect Dis; 2007 Aug; 45(4):459-66. PubMed ID: 17638194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates.
    Afzal MA; Pickford AR; Forsey T; Heath AB; Minor PD
    J Gen Virol; 1993 May; 74 ( Pt 5)():917-20. PubMed ID: 8492099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurovirulence of mumps virus: intraspinal inoculation test in marmosets.
    Saika S; Kidokoro M; Aoki A; Ohkawa T
    Biologicals; 2004 Sep; 32(3):147-52. PubMed ID: 15536045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Community effectiveness of vaccines against infectious parotiditis (mumps). Report of cases].
    Limón Mora J; Molina López T; Domínguez Camacho JC
    Rev Esp Salud Publica; 1999; 73(4):455-64. PubMed ID: 10575934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Laboratory diagnosis of parotitis in the post-vaccination era].
    de la Loma A; Villota J; Varela JM; Alonso M; de Ory F
    Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):119-20. PubMed ID: 12586040
    [No Abstract]   [Full Text] [Related]  

  • 33. [Epidemic parotitis in Italy: results of a 1st vaccination trial].
    Midulla M; Tamburello O; Balducci L; Assensio AM; Finocchiaro M; Chicca A; Sabatino G
    Ann Sclavo; 1977; 19(2):177-86. PubMed ID: 603264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mumps vaccination and morbidity in the Finnish Army 1967-70].
    Vesikari T; Cantell K; Penttinen K
    Sotilaslaak Aikak; 1971; 46(3):75-80. PubMed ID: 5135726
    [No Abstract]   [Full Text] [Related]  

  • 35. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?
    Dayan GH; Rubin S
    Clin Infect Dis; 2008 Dec; 47(11):1458-67. PubMed ID: 18959494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Estimation of the efficacy of three strains of mumps vaccines during an epidemic of mumps in the Geneva canton (Switzerland)].
    Chamot E; Toscani L; Egger P; Germann D; Bourquin C
    Rev Epidemiol Sante Publique; 1998 Mar; 46(2):100-7. PubMed ID: 9592852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A field trial with live attenuated mumps virus vaccine: a serological study.
    Rossier E; Meunier J; Baker F; Marchessault V
    Can J Microbiol; 1971 Jul; 17(7):929-34. PubMed ID: 5094603
    [No Abstract]   [Full Text] [Related]  

  • 38. Mumps control today.
    Quinlisk MP
    J Infect Dis; 2010 Sep; 202(5):655-6. PubMed ID: 20662719
    [No Abstract]   [Full Text] [Related]  

  • 39. Mumps vaccine virus strains and aseptic meningitis.
    Bonnet MC; Dutta A; Weinberger C; Plotkin SA
    Vaccine; 2006 Nov; 24(49-50):7037-45. PubMed ID: 16884835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenicity of mumps virus in the marmoset.
    Saika S; Kidokoro M; Ohkawa T; Aoki A; Suzuki K
    J Med Virol; 2002 Jan; 66(1):115-22. PubMed ID: 11748667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.